Literature DB >> 10400813

Expression of the coxsackievirus and adenovirus receptor in cultured human umbilical vein endothelial cells: regulation in response to cell density.

S D Carson1, J T Hobbs, S M Tracy, N M Chapman.   

Abstract

Primary cultures of human umbilical vein endothelial cells (HUVEC) express the human coxsackievirus and adenovirus receptor (HCAR). Whereas HCAR expression in HeLa cells was constant with respect to cell density, HCAR expression in HUVEC increased with culture confluence. HCAR expression in HUVEC was not quantitatively altered by infection with coxsackievirus B.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10400813      PMCID： PMC112800     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  12 in total

1.  Persistent infection of human vascular endothelial cells by group B coxsackieviruses.

Authors:  P G Conaldi; C Serra; A Mossa; V Falcone; F Basolo; G Camussi; A Dolei; A Toniolo
Journal:  J Infect Dis       Date:  1997-03       Impact factor: 5.226

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells.

Authors:  D R Shafren; D T Williams; R D Barry
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Purification of the putative coxsackievirus B receptor from HeLa cells.

Authors:  S D Carson; N N Chapman; S M Tracy
Journal:  Biochem Biophys Res Commun       Date:  1997-04-17       Impact factor: 3.575

5.  Sites other than nucleotide 234 determine cardiovirulence in natural isolates of coxsackievirus B3.

Authors:  N M Chapman; J R Romero; M A Pallansch; S Tracy
Journal:  J Med Virol       Date:  1997-07       Impact factor: 2.327

6.  Functional diversity in vascular endothelial cells: role in coxsackievirus tropism.

Authors:  S A Huber; C Haisch; P A Lodge
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

7.  An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses.

Authors:  N M Chapman; Z Tu; S Tracy; C J Gauntt
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

8.  The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region.

Authors:  Z Tu; N M Chapman; G Hufnagel; S Tracy; J R Romero; W H Barry; L Zhao; K Currey; B Shapiro
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

9.  Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55).

Authors:  J M Bergelson; J G Mohanty; R L Crowell; N F St John; D M Lublin; R W Finberg
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

10.  Lipopolysaccharide suppresses cytokine release from coxsackie virus-infected human monocytes.

Authors:  A Henke; H P Spengler; A Stelzner; M Nain; D Gemsa
Journal:  Res Immunol       Date:  1992-01
View more
  22 in total

Review 1.  Cell physiology as a variable in gene transfer to endothelium.

Authors:  Philip L Leopold
Journal:  Curr Atheroscler Rep       Date:  2003-05       Impact factor: 5.113

2.  Coxsackievirus expression of the murine secretory protein interleukin-4 induces increased synthesis of immunoglobulin G1 in mice.

Authors:  N M Chapman; K S Kim; S Tracy; J Jackson; K Höfling; J S Leser; J Malone; P Kolbeck
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Variations of coxsackievirus B3 capsid primary structure, ligands, and stability are selected for in a coxsackievirus and adenovirus receptor-limited environment.

Authors:  Steven D Carson; Nora M Chapman; Susan Hafenstein; Steven Tracy
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

4.  Disruption of 3D tissue integrity facilitates adenovirus infection by deregulating the coxsackievirus and adenovirus receptor.

Authors:  M Anders; R Hansen; R-X Ding; K A Rauen; M J Bissell; W Michael Korn
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-07       Impact factor: 11.205

5.  Cytokine-mediated downregulation of coxsackievirus-adenovirus receptor in endothelial cells.

Authors:  Theresa Vincent; Ralf F Pettersson; Ronald G Crystal; Philip L Leopold
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

6.  Fiber and penton base capsid modifications yield diminished adenovirus type 5 transduction and proinflammatory gene expression with retention of antigen-specific humoral immunity.

Authors:  John W Schoggins; Erik Falck-Pedersen
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

7.  Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.

Authors:  S Tracy; K M Drescher; N M Chapman; K-S Kim; S D Carson; S Pirruccello; P H Lane; J R Romero; J S Leser
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

8.  Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds.

Authors:  Alexander Stoff; Angel A Rivera; N S Banerjee; J Michael Mathis; Antonio Espinosa-de-los-Monteros; Long P Le; Jorge I De la Torre; Luis O Vasconez; Thomas R Broker; Dirk F Richter; Mariam A Stoff-Khalili; David T Curiel
Journal:  Wound Repair Regen       Date:  2006 Sep-Oct       Impact factor: 3.617

9.  Characterization of coxsackievirus B3 replication in human umbilical vein endothelial cells.

Authors:  A Kühnl; C Rien; K Spengler; N Kryeziu; A Sauerbrei; R Heller; A Henke
Journal:  Med Microbiol Immunol       Date:  2014-03-11       Impact factor: 3.402

10.  Enhanced Gene Delivery to Human Primary Endothelial Cells Using Tropism-Modified Adenovirus Vectors.

Authors:  Meredith A Preuss; Joel N Glasgow; Maaike Everts; Mariam A Stoff-Khalili; Hongju Wu; David T Curiel
Journal:  Open Gene Ther J       Date:  2008-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.